Journal of Endocrinological Investigation

, Volume 12, Issue 11, pp 823–829 | Cite as

Persistence of low serum thyroid hormone levels in a Graves’ disease patient receiving supraphysiologic L-thyroxine replacement therapy

  • B. N. Premachandra
  • T. W. Burns
  • R. Bregant
  • I. K. Williams
  • K. D. Burman
Case Report
First Online:
Received:
Accepted:

Abstract

A patient with Graves’ disease was treated with radioactive iodine. For several years following treatment, the patient displayed clinical hypothyroidism and persistently low serum thyroxine (T4) and triiodothyronine (T3) levels despite large T4 replacement dosage (0.3–0.4 mg L-thyroxine daily). A defect in T4 absorption was considered unlikely since absorption of fat soluble materials (vitamins A and E) was essentially normal as reflected by their serum concentrations. Abnormalities in serum protein binding of T4 especially by immunoglobulins were suspected; however, thyroid hormone binding antibodies were absent. Thyroxine binding prealbumin (TBPA) levels were either frankly elevated or in the upper normal range and such variations were mirrored by retinol binding protein (RBP) concentrations. Thyroxine binding globulin (TBG) concentration was normal. A surprising finding was an elevated percent dialyzable thyroxine (.041%; normal range,.018–.034%) in spite of a normal concentration of TBG. Serum free fatty acid levels were also elevated. The marked increase in percent free T4 (FT4) fraction together with a low serum total T4 concentration resulted in normal or marginally elevated FT4 levels. An increase in T4 metabolic clearance as suggested by the elevated percent FT4 fraction was corroborated by steady state serum T4 values observed following changes in T4 dosage. It is suggested that this factor may explain the persistence of low TH levels and hypothyroidism in spite of this patient receiving supraphysiologic T4 replacement doses. The clinical significance of these observations is briefly noted.

Key-words

Graves’ disease low T4 in Graves’disease T4 clearance in Graves’disease low T4 during T4 therapy 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Oppenheimer J.H., Surks M.I. Kinetics of iodine metabolism: Hormonal distribution and turnover. In: Werner S.C., Ingbar S.H. (Eds.), The thyroid. Harper and Row Publishers, New York, 1971, p. 66.Google Scholar
  2. 2.
    Hesch R.D. The low T3 syndrome. Academic Press, New York, 1981, vol. 40.Google Scholar
  3. 3.
    Winkler A., Wilson D. Thyroid acropachy. Mo. Med. 82: 756, 1985.PubMedGoogle Scholar
  4. 4.
    Premachandra B.N., Perlstein I.B., Blumenthal HT. Studies on obesity. II. Slowmoving thyroxine binding globulin in the sera of normal and obese subjects. J. Clin. Endocrinol. Metab. 30: 752, 1970.PubMedCrossRefGoogle Scholar
  5. 5.
    Sterling K., Brenner M.A. Free thyroxine in human serum: Simplified measurement with the aid of magnesium precipitation. J. Clin. Invest. 45: 153, 1966.PubMedCrossRefGoogle Scholar
  6. 6.
    Weber F. Absorption mechanisms for fat-soluble vitamins and the effect of other food constituents. In: Harper A.E., Davis G.K. (Eds.), Nutrition in health and disease and international development, progress in clinical and biological research. Alan R. Liss, Inc., New York, 1981, vol. 77, p. 119.Google Scholar
  7. 7.
    Krenning E.P., Docter R., Visser T.J., Hennemann G. Plasma membrane transport of thyroid hormone: its pathophysiological significance. J. Endocrinol. Invest. 6: 59, 1983.PubMedCrossRefGoogle Scholar
  8. 8.
    Fish L.H., Schwartz H.L., Cavanaugh J., Steffes M.W., Bantle J.P., Oppenheimer J.H. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: Role of triiodothyronine in pituitary feedback in humans. N.Engl.J. Med. 316: 764, 1987.PubMedCrossRefGoogle Scholar
  9. 9.
    Chopra I.J., Solomon D.H., Chua Teco G.N., Eisenberg J.B. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 215: 407, 1982.PubMedCrossRefGoogle Scholar
  10. 10.
    Oppenheimer J.H., Schwartz H.L., Mariash C.N., Kaiser F.E. Evidence for a factor in the sera of patients with nonthyroidal disease which inhibits iodothyronine binding by solid matrices, serum proteins, and rat hepatocytes. J. Clin. Endocrinol. Metab. 54: 757, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Woeber K.A., Maddux B.A. Thyroid hormone binding in nonthyroid illness. Metabolism 30: 412, 1981.PubMedCrossRefGoogle Scholar
  12. 12.
    Stockigt J.R., Lim C-F., Barlow J.W., Wynne K.N., Mohr V.S., Topliss D.J., Hamblin P.S., Sabto J. Interaction of furosemide with serum thyroxine-binding sites: In vivo and in vitro studies and comparison with other inhibitors. J. Clin. Endocrinol. Metab. 60: 1025, 1985.PubMedCrossRefGoogle Scholar
  13. 13.
    Morley J.E, Russell R.M., Reed A., Carney E.A., Hershman J.M. The interrelation of thyroid hormones with vitamin A and zinc nutrition status in patients with chronic hepatic and gastrointestinal disorders. Am. J. Clin. Nutr. 34: 1489, 1981.PubMedGoogle Scholar
  14. 14.
    Kirkeby K. Fatty acid composition of serum lipids in hyper- and hypothyroidism. Acta Endocrinol. (Copenh.)71: 62, 1972.Google Scholar
  15. 15.
    Loeb J.N. Metabolic changes. In: Ingbar S.H., Braverman L.E. (Eds.), Werner’s the thyroid. J.B. Lippincott Co., Philadelphia, 1986, p. 1208.Google Scholar
  16. 16.
    Chopra I.J., Chua Teco G.N., Mead J.F., Huang T.S., Beredo A., Solomon D.H. Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroid illnesses. J. Clin. Endocrinol. Metab. 60: 980, 1985.PubMedCrossRefGoogle Scholar
  17. 17.
    Tabachnick M., Korcek L. Effect of long-chain fatty acids on the binding of T4 and T3 to human thyroxine-binding globulin (TBG). In: Medeiros-Neto G., Gaitan E. (Eds.), Frontiers in thyroidology. Plenum Medical Book Co., New York, 1985, vol. 1, p. 491.Google Scholar
  18. 18.
    Mendel C.M., Front P.H., Cavalieri R.R. Effect of free fatty acids on the concentration of free thyroxine in human serum: The role of albumin. J. Clin. Endocrinol. Metab. 63: 1394, 1986.PubMedCrossRefGoogle Scholar
  19. 19.
    Liewendahl K., Tikanoja S., Mahonen H., Helenius T., Vallmaki M., Tallgren L.G. Concentrations of iodothyronines in serum of patients with chronic renal failure and other nonthyroidal illnesses: Role of free fatty acids. Clin. Chem. 33: 1382, 1987.PubMedGoogle Scholar
  20. 20.
    De Visscher M. The thyroid gland. Raven Press, New York, 1980.Google Scholar
  21. 21.
    Kanai M., Raz A., Goodman D.S. Retinol binding protein: the transport protein for vitamin A in human plasma. J. Clin. Invest. 47: 2025, 1968.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Larsen P.R. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N. Engl. J. Med. 306: 23, 1982.PubMedCrossRefGoogle Scholar
  23. 23.
    Rall J.E., Robbins J., Lewallen C.G. The Thyroid. In: Pincus G., Thimann K.V., Astwood E.B. (Eds.), The hormones. Academic Press, New York, 1964, vol. V, p. 159.CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1989

Authors and Affiliations

  • B. N. Premachandra
    • 1
  • T. W. Burns
    • 2
  • R. Bregant
    • 2
  • I. K. Williams
    • 1
  • K. D. Burman
    • 3
  1. 1.Veterans Administration Medical CenterJefferson BarracksSt. Louis
  2. 2.Department of MedicineUniversity of Missouri, ColumbiaMissouri
  3. 3.Departments of Medicine and Clinical Investigation, Kyle Metabolic UnitWalter Reed Army Medical CenterWashingtonUSA

Personalised recommendations